Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ).
Alembic Pharmaceuticals Limited has announced a newspaper advertisement regarding the transfer of shares from its Unclaimed Suspense Account to the claimant’s demat account. This move is part of the company’s compliance with regulatory requirements, ensuring that unclaimed shares are properly managed and transferred to rightful owners, thereby maintaining transparency and accountability in its operations.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its diverse range of generic formulations and active pharmaceutical ingredients, catering to both domestic and international markets.
Average Trading Volume: 11,346
Technical Sentiment Signal: Buy
Current Market Cap: 181.2B INR
Learn more about APLLTD stock on TipRanks’ Stock Analysis page.